Spyre Therapeutics (NasdaqGS:SYRE) 2026 Conference March 09, 2026 08:40 AM ET Company ParticipantsCameron Turtle - CEOSheldon Sloan - Chief Medical OfficerConference Call ParticipantsTom Smith - Senior Managing Director and Senior Biotechnology AnalystTom SmithGood morning, everyone. Thanks for joining us here at the Leerink Partners Global Healthcare Conference. My name's Tom Smith. I'm one of the senior biotech analysts here at Leerink, and it's my pleasure to introduce our next company, Spyre Therapeutic ...